Oncolytics Biotech Inc
(ONCY)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2021 | 09-2021 | 06-2021 | 03-2021 | 12-2020 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 32,923 | 38,201 | 41,361 | 39,776 | 23,305 |
| Receivables | 691 | 200 | 111 | 88 | 67 |
| TOTAL | $35,829 | $40,986 | $45,139 | $42,140 | $25,184 |
| Non-Current Assets | |||||
| PPE Net | 313 | 271 | 119 | 170 | 177 |
| Other Non-Current Assets | 466 | 524 | 590 | 481 | 278 |
| TOTAL | $779 | $795 | $709 | $652 | $455 |
| Total Assets | $36,608 | $41,780 | $45,847 | $42,792 | $25,639 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 1,586 | 1,854 | 1,786 | 1,515 | 1,347 |
| Other current liabilities | 326 | 84 | 125 | 188 | 489 |
| TOTAL | $2,146 | $2,152 | $2,102 | $1,902 | $2,022 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 5,658 | 5,698 | 5,895 | 5,609 | 5,139 |
| TOTAL | $5,658 | $5,698 | $5,895 | $5,609 | $5,139 |
| Total Liabilities | $7,804 | $7,850 | $7,998 | $7,512 | $7,161 |
| Shareholders' Equity | |||||
| Common Shares | 312,257 | 310,743 | 318,454 | 302,465 | 266,369 |
| Retained earnings | -313,906 | -306,372 | -310,041 | -295,027 | -274,049 |
| Other shareholders' equity | 3,196 | 3,197 | 3,199 | 3,141 | 2,999 |
| TOTAL | $28,803 | $33,930 | $37,850 | $35,280 | $18,478 |
| Total Liabilities And Equity | $36,608 | $41,780 | $45,847 | $42,792 | $25,639 |